1402 related articles for article (PubMed ID: 19008712)
41. Uric acid: role in cardiovascular disease and effects of losartan.
Alderman M; Aiyer KJ
Curr Med Res Opin; 2004 Mar; 20(3):369-79. PubMed ID: 15025846
[TBL] [Abstract][Full Text] [Related]
42. Hyperuricemia is a mediator of endothelial dysfunction and inflammation in renal allograft recipients.
Karbowska A; Boratynska M; Kusztal M; Klinger M
Transplant Proc; 2009 Oct; 41(8):3052-5. PubMed ID: 19857674
[TBL] [Abstract][Full Text] [Related]
43. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells.
Kang DH; Park SK; Lee IK; Johnson RJ
J Am Soc Nephrol; 2005 Dec; 16(12):3553-62. PubMed ID: 16251237
[TBL] [Abstract][Full Text] [Related]
44. Mild hyperuricemia induces glomerular hypertension in normal rats.
Sánchez-Lozada LG; Tapia E; Avila-Casado C; Soto V; Franco M; Santamaría J; Nakagawa T; Rodríguez-Iturbe B; Johnson RJ; Herrera-Acosta J
Am J Physiol Renal Physiol; 2002 Nov; 283(5):F1105-10. PubMed ID: 12372787
[TBL] [Abstract][Full Text] [Related]
45. Effect of bis (maltolato) oxovanadium (BMOV) in uric acid and sodium arsenite-induced vascular endothelial dysfunction in rats.
Jindal S; Singh M; Balakumar P
Int J Cardiol; 2008 Aug; 128(3):383-91. PubMed ID: 17658639
[TBL] [Abstract][Full Text] [Related]
46. Preconditioning protects endothelium by preventing ET-1-induced activation of NADPH oxidase and xanthine oxidase in post-ischemic heart.
Duda M; Konior A; Klemenska E; Beresewicz A
J Mol Cell Cardiol; 2007 Feb; 42(2):400-10. PubMed ID: 17156794
[TBL] [Abstract][Full Text] [Related]
47. Oxidative stress with an activation of the renin-angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction.
Yu MA; Sánchez-Lozada LG; Johnson RJ; Kang DH
J Hypertens; 2010 Jun; 28(6):1234-42. PubMed ID: 20486275
[TBL] [Abstract][Full Text] [Related]
48. Astilbin attenuates hyperuricemia and ameliorates nephropathy in fructose-induced hyperuricemic rats.
Chen L; Lan Z; Zhou Y; Li F; Zhang X; Zhang C; Yang Z; Li P
Planta Med; 2011 Nov; 77(16):1769-73. PubMed ID: 21614752
[TBL] [Abstract][Full Text] [Related]
49. Iptakalim ameliorates MPP+-induced astrocyte mitochondrial dysfunction by increasing mitochondrial complex activity besides opening mitoK(ATP) channels.
Zhang S; Ding JH; Zhou F; Wang ZY; Zhou XQ; Hu G
J Neurosci Res; 2009 Apr; 87(5):1230-9. PubMed ID: 19006086
[TBL] [Abstract][Full Text] [Related]
50. Cyclooxygenase inhibition with acetylsalicylic acid unmasks a role for prostacyclin in erythropoietin-induced hypertension in uremic rats.
Rodrigue ME; Lacasse-M S; Larivière R; Lebel M
Can J Physiol Pharmacol; 2005 Jun; 83(6):467-75. PubMed ID: 16049546
[TBL] [Abstract][Full Text] [Related]
51. Uric acid heralds ischemic tissue injury to mobilize endothelial progenitor cells.
Patschan D; Patschan S; Gobe GG; Chintala S; Goligorsky MS
J Am Soc Nephrol; 2007 May; 18(5):1516-24. PubMed ID: 17409313
[TBL] [Abstract][Full Text] [Related]
52. Protective effects of iptakalim, a novel ATP-sensitive potassium channel opener, on global cerebral ischemia-evoked insult in gerbils.
Chen H; Yang Y; Yao HH; Tang XC; Ding JH; Wang H; Hu G
Acta Pharmacol Sin; 2006 Jun; 27(6):665-72. PubMed ID: 16723083
[TBL] [Abstract][Full Text] [Related]
53. Hyperuricemia attenuates aortic nitric oxide generation, through inhibition of arginine transport, in rats.
Schwartz IF; Grupper A; Chernichovski T; Grupper A; Hillel O; Engel A; Schwartz D
J Vasc Res; 2011; 48(3):252-60. PubMed ID: 21099230
[TBL] [Abstract][Full Text] [Related]
54. Vascular and cardiac overexpression of endothelin-1 gene in one-kidney, one clip Goldblatt hypertensive rats but only in the late phase of two-kidney one clip Goldblatt hypertension.
Sventek P; Turgeon A; García R; Schiffrin EL
J Hypertens; 1996 Jan; 14(1):57-64. PubMed ID: 12013496
[TBL] [Abstract][Full Text] [Related]
55. eNOS gene delivery prevents hypertension and reduces renal failure and injury in rats with reduced renal mass.
Savard S; Lavoie P; Villeneuve C; Agharazii M; Lebel M; Larivière R
Nephrol Dial Transplant; 2012 Jun; 27(6):2182-90. PubMed ID: 22121231
[TBL] [Abstract][Full Text] [Related]
56. Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase.
Wang Y; Huang Y; Lam KS; Li Y; Wong WT; Ye H; Lau CW; Vanhoutte PM; Xu A
Cardiovasc Res; 2009 Jun; 82(3):484-92. PubMed ID: 19251722
[TBL] [Abstract][Full Text] [Related]
57. The role of ATP-sensitive potassium channel blockers in ischemia-reperfusion-induced renal injury versus their effects on cardiac ischemia reperfusion in rats.
Tawfik MK; Abo-Elmatty DM; Ahmed AA
Eur Rev Med Pharmacol Sci; 2009; 13(2):81-93. PubMed ID: 19499842
[TBL] [Abstract][Full Text] [Related]
58. Lipoic acid supplementation prevents cyclosporine-induced hypertension and nephrotoxicity in spontaneously hypertensive rats.
Louhelainen M; Merasto S; Finckenberg P; Lapatto R; Cheng ZJ; Mervaala EM
J Hypertens; 2006 May; 24(5):947-56. PubMed ID: 16612258
[TBL] [Abstract][Full Text] [Related]
59. [Clinical implication of endothelial dysfunction in patients with essential arterial hypertension and urate dysbolism with renal damage].
Ter Arkh; 2011; 83(10):36-40. PubMed ID: 22185023
[TBL] [Abstract][Full Text] [Related]
60. Insulin activates ATP-sensitive potassium channels via phosphatidylinositol 3-kinase in cultured vascular smooth muscle cells.
Yasui S; Mawatari K; Kawano T; Morizumi R; Hamamoto A; Furukawa H; Koyama K; Nakamura A; Hattori A; Nakano M; Harada N; Hosaka T; Takahashi A; Oshita S; Nakaya Y
J Vasc Res; 2008; 45(3):233-43. PubMed ID: 18097147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
